Article

Five-year NIH grant to aid AMD research

The National Eye Institute of the National Institutes of Health has awarded a 5-year, $14.6 million grant to fund a study of age-related macular degeneration.

The National Eye Institute of the National Institutes of Health (NIH) has awarded a 5-year, $14.6 million grant to fund a study of age-related macular degeneration (AMD).

The grant will finance an international, interdisciplinary effort led by the University of Iowa to leverage two recent genetic discoveries into possible treatments for AMD.

Gregory Hageman, PhD, professor of ophthalmology and visual sciences at the University of Iowa Roy J. and Lucille A. Carver College of Medicine, will lead the multi-institutional effort.In the past year, the University of Iowa, Columbia University Medical Center, and the National Cancer Institute, along with others, determined that two genes -- those for complement factor H and factor B -- account for nearly three out of four cases of AMD.

The scientists will investigate the genes' role in the immune system, with the goal of developing diagnostic tools and treatment.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Dr. Wendy Lee at Controversies in Modern Eyecare 2025
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
© 2025 MJH Life Sciences

All rights reserved.